Phastar is an award-winning biometrics and data science CRO, trusted by pharma, biotech, and medical device companies worldwide. With a global team of data specialists, we bring expertise, precision, and pace to every trial—because behind every data point is a patient waiting for treatment. We don’t just deliver on-time high quality data; we partner with you to turn complexity into clarity. Leveraging best-in-class technology, AI-enhanced analytics, advanced statistical methods, and deep therapeutic expertise, we accelerate regulatory approvals, ensure compliance with global standards and seamlessly mitigate risk. Our proven track record in transforming complex data into clear, actionable intelligence enables you to accelerate drug development. With scalable, tailored solutions, we expedite trials—bringing life-changing therapies to patients faster.
PharSafer
Founded in 2003 by Dr Graeme Ladds, PharSafer® is a specialist Contract Research Organisation (CRO) in Global Clinical and Post Marketing Drug Safety, and Medical Services, with a wealth of experience in Pharmacovigilance, Auditing and Medical Affairs – and the various, numerous and extensive legal safety/medical obligations for licence holders to comply with – as well as Regulatory Strategy for the best methods for obtaining scientific advice concerning licence submissions and approvals. Together with our sister company which focuses on Training: SaPhar, PharSafer® continuously seeks new and innovative ways to provide added value for our global clients – going above and beyond expectations and optimising processes and procedures involved with clinical and post marketing drug safety and licencing approach. Our ability to offer first-class services in Pharmacovigilance, Regulatory Affairs, Training, Auditing, Medical Affairs and IT Informatics means that, for many clients, we operate as their Pharmacovigilance and Medical Departments – guiding them through the labyrinth of drug safety and medical legislation, all in the interests of ensuring patient safety and client compliance. We love what we do. We love finding solutions. Quite simply, we are by far… Your leading partner in Drug Safety. | PharSafer is a Global CRO specialising in Clinical & Post Marketing Pharmacovigilance; Medical Affairs; Training; Auditing; IT Informatics and Regulatory Intelligence. PharSafer have been operating for the last 23 years growing annually and helping take Companies from their clinical to post-marketing phases and many clients have been with us over 10 years now. PharSafer have attended over 100 inspections on behalf of clients to aid their compliance and ensure Regulatory Authorities are satisfied with the activities being performed. PharSafer are also an innovative Company designing validated and automated systems to provide cost-effective solutions for clients and ensure Regulatory compliant systems. Our client base is truly global being in all continents and for clients that have drugs; devices; vaccines; biologics; advanced therapies; biosimilars; herbal and cosmetics. Our Team within the Company are very experienced (many with over 15 years experience) aided by our sister training Company (SaPhar) to provide new updates for clients on country specific regulations with regular monthly contacts and comments going to all clients. We would be happy to engage with you and talk about product development; product expansions into new countries; product launches and perform all of the activities mentioned above. Please review of website and we look forward to engaging with you personally.
Pharmigene Inc
Established in 2005, Pharmigene Inc. is a leading biotechnology company specializing in pharmacogenomic testing. We hold exclusive global licenses from Academia Sinica for patents related to genetic testing for Warfarin and other critical medications such as Carbamazepine and Allopurinol. Leveraging these proprietary technologies, we have developed advanced diagnostic products and tools that have secured comprehensive technical patent certifications across numerous countries worldwide, including the USA, Europe, New Zealand, Australia, Japan, China, India, and Southeast Asia.Headquartered in Taiwan, Pharmigene operates a state-of-the-art R&D center and maintains stringent quality management systems. Our commitment to excellence is underscored by our certifications, including international ISO 13485, Taiwan QMS (GMP), and South Korea KGMP, ensuring the highest standards in medical device manufacturing and diagnostic solutions.
PharmaCircle
PharmaCircle will be showcasing our Partnership Explorer, a new analysis tool that helps business development professionals to identify external innovation and partnering opportunities. With PharmaCircle’s Partnership Explorer, you can easily explore and evaluate partnered and unpartnered pipeline programs and products by a host of filters including product name, molecule/API name, target name, company name, indication/disease area, molecule/API type, target type, mechanism type, phase, route, country/region, drug delivery category, and dosage form. PharmaCircle’s business intelligence and prospecting tools explore the business portfolios, capabilities, and transactions of more than 32,000 commercial and emerging stage life sciences companies and suppliers from around the world. PharmaCircle’s search and analysis tools include the Partnership Explorer; Terminated Programs Tracker; Strategic Deals Analyzer; Venture Capital & Funding Tracker; Pipeline & Products Intelligence with Formulation Details; Product Sales, Forecast & Unit Pricing Data; Company Profile PDF Reports; Disease Area PDF Reports; Epidemiology Explorer; Trial Landscape Explorer; Patent Exclusivity Tracker; Drug Delivery Technology Analyzer; CMOCRO Explorer; Prospector Business Development Map Tool; Spyglass Personalized Weekly Email News Brief. Since 2003, PharmaCircle has been providing commercial and emerging stage life sciences companies and suppliers the integrated data, powerful analysis tools and industry knowledge needed to solve complex, real-world challenges in product development and innovation. To see how we can help you, please visit our booth #1243 or website www.pharmacircle.com | PharmaCircle will be showcasing Partnership Explorer, a powerful analysis tool that helps business development professionals to identify external innovation and partnering opportunities, and enhancements to our Professional Subscription Service of business intelligence and prospecting solutions. With PharmaCircle’s Partnership Explorer, you can easily explore and evaluate more than 25,000 unpartnered programs and products by a host of filters, identify country/regional licensing opportunities, and track in-licensed and out-licensed products for each company. PharmaCircle’s Professional Subscription Service includes Pipeline & Products Intelligence; Company Profile Reports; Strategic Deals Analysis; Venture Capital & Funding Tracking; Product Sales, Forecast & Pricing; Epidemiology Explorer; Orphan Drug Analytics, Trial Landscape Explorer; Prospector Business Development Map Tool; CMOCRO Explorer; News & Insights; and Spyglass Personalized Weekly Email News Brief. PharmaCircle’s business intelligence and prospecting tools provide a comprehensive view of the business portfolios, capabilities, deals and funding transactions of more than 35,000 commercial and emerging stage life sciences companies and suppliers from around the world. Since 2003, PharmaCircle has been providing commercial and emerging stage life sciences companies and suppliers the integrated data, powerful analysis tools and industry knowledge needed to solve complex, real-world challenges in product development and innovation. To see how we can help you, please visit our booth #4155 or website www.pharmacircle.com. | PharmaCircle provides the curated data, powerful analysis tools and industry knowledge needed to solve complex, real-world challenges in drug product development and innovation. PharmaCircle’s search and evaluation tools identify unpartnered pipeline program opportunities and examine the pipeline/product portfolios and business transactions of commercial and emerging stage life sciences companies and their suppliers. PharmaCircle has been curating pharma pipeline intelligence, formulation/drug delivery information, and supply chain insights for more than 20 years. Our team of product developers and customer support personnel is comprised of scientists and business analysts from the life sciences industry. Many life sciences innovators and manufacturers rely on PharmaCircle’s curated content and expert analyses for mission-critical projects, and reference our data in conference presentations and published articles.
Owkin
Owkin is an Agentic AI company pioneering the use of data, biology, and AI to decode the fundamental mechanics of disease and advance medical science. By focusing on the system’s ability to uncover biology’s ground truth at scale, Owkin aims to revolutionize the way we diagnose and treat diseases. With a vision of achieving a “positive singularity” in medicine, Owkin leverages AI to deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional pharmaceutical approaches often cannot solve. Owkin also founded MOSAIC, the world’s largest spatial multi-omics atlas for cancer research across nine cancer indications. Owkin has raised over $300 million through investments from leading biopharma companies, including Sanofi and BMS, and venture funds like F-Prime, GV and Bpifrance, among others.
NOF CORPORATION
NOF CORPORATION is the leading commercial supplier of drug delivery products such as activated PEGs, lipids and ultrapure Polysorbate 80. Our cutting edge products include Pendant type single molecule PEG linkers for ADCs and SS-lipids for nucleic acid/gene delivery and vaccines.
NIH Technology Transfer
Partner with NIH to bring the next healthcare innovation to market. Partnerships using NIH technologies are behind highly impactful products including HPV vaccines, mRNA COVID-19 vaccines, and more. Check out the expansive collection of leading-edge technologies from award winning NIH inventors available for licensing or collaboration on our website. | Partner with NIH to bring the next healthcare innovation to market. Partnerships using NIH technologies are behind highly impactful products including HPV vaccines, mRNA COVID-19 vaccines, and more. Check out the expansive collection of over 1,700 leading-edge technologies from award winning NIH inventors available for licensing or collaboration on our website, stop by our booth, or set up a partnering meeting with us to discuss a potential collaboration!
NEUROPHET
NEUROPHET Inc., Seoul, Republic of Korea, with expertise in neuroscience. We have been focusing on developing and providing innovative medical solutions for helping patients suffering from neurological diseases. To achieve the mission, we have applied state-of-the-art AI technologies to our expertise in neuroimaging, brain modeling and neuromodulation. We are conducting research in imaging-based biomarkers for Alzheimer’s disease (AD), which will be valuable tool for clinical trials (surrogate biomarker for drug response and disease progression) and companion diagnostics for AD therapeutics and furthermore, global standardization for AD staging and diagnostics. Neurophet provides medical-grade solutions approved by international regulatory bodies. | Neurophet Inc. develops advanced AI-powered neuroimaging solutions to enhance the diagnosis, monitoring, and treatment planning of neurological disorders. Its flagship products—AQUA AD, AQUA, and SCALE PET—deliver precise, quantitative insights into brain atrophy, lesion dynamics, and imaging biomarkers, including those associated with amyloid-targeted therapeutics (ATT) and amyloid-related imaging abnormalities (ARIA), through MRI and PET imaging. | Neurophet is a specialized company developing AI-powered brain imaging analysis solutions and therapeutic medical devices, covering the full cycle of neurological care — from MRI and PET analysis to wearable brain stimulation devices. We support medical institutions with AI-based imaging for diagnosis and treatment monitoring, and provide standardized central imaging services for global pharmaceutical clinical trials through our Imaging Core Lab (ICL). From the clinical frontline to global clinical trials, Neurophet is advancing as a global leader in neurological imaging analysis.